Santanu Maji

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Breast Cancer Cells

Protein Protein

Endoplasmic Reticulum Stress

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Anjan K Pradhan, Jinkal Modi, Santanu Maji, Amit Kumar, Praveen Bhoopathi, Padmanabhan Mannangatti, Chunqing Guo, Daniel K Afosah, Mark C Mochel, Nitai D Mukhopadhyay, Joanne M Jeter, Xiang-Yang Wang, Umesh R Desai, Devanand Sarkar, Luni Emdad, Swadesh K Das, Paul B Fisher
Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis. Molecular cancer therapeutics (2023)
Santanu Maji, Anjan K Pradhan, Amit Kumar, Praveen Bhoopathi, Padmanabhan Mannangatti, Chunqing Guo, Jolene J Windle, Mark A Subler, Xiang-Yang Wang, Oliver John Semmes, Julius O Nyalwidhe, Nitai Mukhopadhyay, Asit Kr Paul, Bryce Hatfield, Michael M Levit, Esha Madan, Devanand Sarkar, Luni Emdad, David J Cohen, Rajan Gogna, Webster K Cavenee, Swadesh K Das, Paul B Fisher
MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis. Proceedings of the National Academy of Sciences of the United States of America 120 (45) (2023)
Anjan K Pradhan, Santanu Maji, Praveen Bhoopathi, Sarmistha Talukdar, Padmanabhan Mannangatti, Chunqing Guo, Xiang-Yang Wang, Lorraine Colon Cartagena, Michael Idowu, Joseph W Landry, Devanand Sarkar, Luni Emdad, Webster K Cavenee, Swadesh K Das, Paul B Fisher
Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β. Proceedings of the National Academy of Sciences of the United States of America 118 (21) (2021)
Yetirajam Rajesh, Angana Biswas, Utkarsh Kumar, Indranil Banerjee, Subhayan Das, Santanu Maji, Swadesh K Das, Luni Emdad, Webster K Cavenee, Mahitosh Mandal, Paul B Fisher
Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma. Proceedings of the National Academy of Sciences of the United States of America 117 (22) (2020)